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Abstract
Nucleotides present an important role in ocular physiology, which has been demonstrated by recent works that indicate
their involvement in many ocular processes. P2Y are important among P2 receptors since they can control tear
production, corneal wound healing, aqueous humour dynamics and retinal physiology. Commercial antibodies have
allowed us to investigate the distribution of P2Y receptors in the cornea, anterior and posterior chamber of the eye and
retina. The P2Y1 receptor was present mainly in cornea, ciliary processes, and trabecular meshwork. The P2Y2 receptors
were present in cornea, ciliary processes and retinal pigmented epithelium. P2Y4 was present in cornea, ciliary processes,
photoreceptors, outer plexiform layer and ganglion cell layer. The P2Y6 presented almost an identical distribution as the
P2Y4 receptor. The P2Y11 was also detectable in the retinal pigmented epithelium. The detailed distribution of the
receptors clearly supports the recent findings indicating the relevant role of nucleotides in the ocular function.
Introduction
There is a general knowledge of nucleotides acting as
extracellular messengers in tissues [1]. Among the tissues/
organs which are under investigation, the eye is one that
has not been fully investigated; it has been taken into
consideration only in recent times, mainly because
nucleotides seem to have interesting physiological roles
and putative therapeutic applications (for a review, see
Pintor [2]).
A quick review of the existing literature in the nucleotide
field of the eye will emphasise the importance of metabo-
tropic P2Y receptors in the ocular structure. For instance,
P2Y receptors can produce an increase in the proportion of
the mucin layer in the tear film [3]. Also, uridine
nucleotides can modify chloride currents facilitating the
production of the aqueous component of the tear [4, 5].
Inside the eye, P2Y receptors are able to regulate the
production and the drainage of the aqueous humour due to
their presence in the ciliary processes and trabecular
meshwork cells [6, 7]. Finally, metabotropic nucleotide
receptors have been described in the neural and non-neural
retina [8–11].
Despite the fact that P2Y receptors seem widely
distributed in the ocular surface and in other ocular areas,
one needs to be aware that frequently the existence of those
receptors has been pharmacologically demonstrated in
primary cell cultures or in cell lines rather than in the
native tissues. Apart from this, another important point is
that the cells under investigation may contain more than
one P2 purinoceptor subtype. This fact makes difficult the
interpretation of the pharmacological data, avoiding very
often a clear picture of the P2 receptors present in a tissue.
For these reasons, in the present experimental work we
present the distribution of P2Y receptors in the rat eye by
means of commercial antibodies. We hope that this
Fpicture` will help researchers to better understand the role
of nucleotides in the eye.
Materials and methods
Immunohistochemistry
A total of 10 Wistar rats of 13 days postnatal (P13) were
sacrificed by rapid decapitation. For the immunohisto-
chemical study, the eyes were removed and were fixed
overnight at 4 -C, using 4% paraformaldehyde in phos-
phate buffer, pH 7.2. After fixation, the eyes were
submitted to a cryoprotective process. Sections of 14 mm
were made using a Leica 3050 M cryostate. Immunohis-
tochemical studies were performed starting with the
following primary antibody dilutions: anti-P2Y1, 1/200;
anti-P2Y2, l/500; anti-P2Y4, 1/500; anti-P2Y6, 1/200 and
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anti-rabbit IgG-TRITC from Sigma (T-6778). In the case
of double immunostaining, we used as primary antibodies
mouse anti-synaptophysin (Sigma, S-5768) 1/250, as a
neuronal marker, mouse anti-vimentin (Sigma, V-6630)
1/500, as a marker of the protein vimentin. As secondary
antibodies we used goat anti-IgG mouse-FITC (Sigma,
F-4014), 1/500 in the case of anti-synaptophysin marker,
and goat anti-IgM mouse-FITC (Sigma, F-9259), l/100
for the anti-vimentin marker. Controls were carried out by
following the same procedures but the primary antibody
was substituted by the same volume of PSS/BSA solution.
Eye sections were analysed by confocal microscopy
using a Zeiss Axiovert 200M microscope equipped with a
LSM5 Pascal confocal module. Sections were observed
with a Zeiss 63 oil immersion lens, numerical aperture
1.40. FITC was monitored by excitation with the 488-nm
wavelength laser, and TRITC was excited at 543-nm
wavelength. All the images were managed with the
LSM5 Pascal software.
Western blotting
For Western blot analysis, the eyes were rapidly removed
and the different parts were placed on ice and subsequently
homogenised with lysis buffer that contains HEPES 50
mM pH 7.5, Triton 2.5% (w/v), EDTA 10 mM, PMSF 0.2
mM and leupeptin 5 mg/ml. Protein samples (40 mg) were
separated by SDS-PAGE (10% acrylamide gel) using the
Bio-Rad Mini-Protein
\ 3-Cell System. Proteins were
transferred to nitrocellulose membranes. Following trans-
fer, the membranes were washed, blocked and incubated.
The dilutions of primary antibodies were as follows: anti-
P2Y1, 1/200; anti-P2Y2, 1/500; anti-P2Y4, l/200; anti-
P2Y6, l/200 and anti-P2Y11, l/1000. As secondary antibody
mouse anti-rabbit IgG coupled to horseradish peroxidase,
from Sigma (A-2074) at 1/1000 dilution were used. Blots
were developed using the Enhanced Chemiluminiscence
detection system (Amersham).
Chemicals
Antibodies against the P2Y receptors were purchased from
Alomone Labs (Israel), except P2Y11 which was a gift from
Dr D. Cousens (Glaxo-Smithkline). Anti-synaptophysin and
anti-vimentin antibodies were from Sigma (St. Louis,
Missouri, USA). Other reagents were analytical grade from
Merck (Darmstadt, Germany).
Results
P2Y receptors in the cornea
The cornea is the most external and transparent part of the
eye. This eye region is formed by five to six different
layers. The most relevant ones include the epithelium, the
most superficial one; the stroma, the thickest; and
endothelium the inner one. The distribution of the
purinergic receptors present in the cornea can be carried
out by making slices and performing immunohistochemis-
try, as described in Materials and methods. The analysis of
the P2Y receptors present in corneal slices, by means of
the available P2Y receptor antibodies, showed that P2Y1,
P2Y2, P2Y4 and P2Y6 antibodies labelled this part of the
eye. Among the different areas of the cornea, the one
which offered positive staining for all receptors was the
epithelial layer (Figure 1), although the intensity of the
labelling was not the same for all the tested antibodies and
for the different areas examined (see Table 1). For
example, the stroma showed a minor label in all the cases
(it only contains some keratinocytes) while the endotheli-
um (the most inner part of the cornea) gave positive results
with the P2Y2,P 2 Y 4 and P2Y6 antibodies (Table 1).
P2Y receptors in the iris and ciliary body
The presence of P2Y1,P 2 Y 2 and P2Y4 was demonstrated
(Table 1) in the iris, which is the structure that works as a
diaphragm, modifying the amount of light entering the eye.
In particular, one of the better staining was achieved with
the P2Y4 receptor antibody (Figure 2). Concerning the
structure of the iris, formed by the dilator muscle and the
sphincter, we tried to see whether or not there were
differences between these two parts concerning the P2Y4
receptor. We have concluded that there were no differences
between these two regions of the iris.
The ciliary body (ciliary processes) is the part of the eye
where the aqueous humour is synthesised. The physiology
of this area is relevant since it is one of the ocular
structures contributing to keep the right pressure within the
eye. An augment of this intraocular pressure can trigger a
pathology termed glaucoma.
The ciliary body contains two types of epithelial cells,
non-pigmented and pigmented ciliary epithelial cells.
The non-pigmented cells are facing the posterior
chamber where the release of the aqueous humour
occurs. The pigmented epithelial cells are just under-
neath the non-pigmented and they limit the stroma that
contains a fenestrated endothelium, which supplies this
ocular region. With the intermediate filament antibody
vimentin, it is possible to visualise the non-pigmented
epithelium and lens capsule (see Figure 3). This
antibody helps to identify these two regions and
provides interesting information when it is applied
together with the P2Y receptor antibodies.
The studies performed with the P2Y receptor antibodies
demonstrated that P2Y1,P 2 Y 2, P2Y4, and P2Y6 gave
positive labelling in this region (Figure 3). Nevertheless,
the distribution was not the same for each antibody. P2Y1,
P2Y2 and P2Y4 marked both, non-pigmented and pig-
mented epithelial cells. In these cases, it was possible to
see that the stroma was also labelled. A different picture
was obtained with the P2Y6 receptor antibody. P2Y6
antibody is concentrated exclusively in the stromal area
and is not a positive labelling in the epithelia (Figure 3).
84 J. Pintor et al.Figure 1. Presence of P2Y receptors in the cornea. Corneal sections
labelled as indicated in Materials and methods, presented positive staining
to P2Y2 (upper panel), P2Y4 (mid panel) and P2Y6 (lower panel), in the
epithelium, and in some cases in the endothelium.
Figure 2. Presence of P2Y4 receptors in the iris. Iris sections presented
positive staining to P2Y4 receptor antibody (in red). Vimentin (to label
intermediate filaments) or synaptophysin (nerve terminals) in green
demonstrated some co-localisation between P2Y4 receptors and the other
markers.
Figure 3. P2Y receptors in the ciliary body and related areas. Positive labelling to P2Y1, P2Y2 (upper panel), P2Y4 (mid panel) and P2Y6 (lower panel)
were observed in the ciliary body (in red). It is noteworthy that the distribution of the receptor depends on the particular P2Y subtype. P2Y2 labelled all
the ciliary body while P2Y6 mainly labelled the stromal area. Vimentin (in green) labels the non-pigmented epithelial cells as well as the lens capsule
and helps to understand the distribution of some of the P2Y receptors.
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is the trabecular meshwork. This area is responsible for
the drainage of the aqueous humour, thereby regulating
intraocular pressure. The immunohistochemical study of
this area permitted us to detect the presence of P2Y1
and P2Y2 receptors, but it was not possible to visualise any
of the other tested (Table 1).
P2Y receptors in the retina
The retina has also been investigated for the presence of
P2Y receptors. Sections of the retina were incubated with
P2Y receptor antibodies as well as with vimentin, which
behaves as a glial cell marker (Mu ¨ller cells marker) in this
region, and synaptophysin, which is a neural marker.
Taking together the combination P2Y/vimentin and
P2Y/synaptophysin allowed us to not only see the presence
of the purinoceptors, but also made it possible for us to
allocate them with specific areas of the retina.
Three P2Y receptor antibodies labelled the retina, the
P2Y2,P 2 Y 4, and P2Y6, (Table 2). P2Y2 presented a strong
labelling in the non-neural retina, i.e. in the retinal
pigmented epithelium (RPE), while other areas were not
significantly stained (Figure 4). It was also possible to
observe inmunolabelling against the P2Y11 antibody on the
RPE, this being the only area where this receptor seems to
be present (Figure 4). The RPE was also labelled with the
P2Y4 antibody, although other areas of the neural retina
were also positive. In this sense, the outer segments of the
photoreceptors, the outer plexifom layer and the ganglion
cell layer, were stained (Figure 5). The P2Y6 presented a
similar distribution pattern labelling the outer segments of
the photoreceptors, outer plexiform layer and ganglion cell
layer. Moreover, the inner plexiform layer was also
labelled with the P2Y6 receptor antibody in clear contrast
with the P2Y4 (Table 2).
Studies on the presence of P2Y receptors in Mu ¨ller cells
were performed with vimentin. These studies demonstrated
the presence of P2Y4 and P2Y6 receptors in this glial cells
(Figure 6). It was not possible to observe any co-local-
isation (results not shown) when the other P2Y receptors
were assayed together with the vimentin.
Western blot analysis
Western blots were carried out by taking samples of the
different areas under study following the protocol de-
scribed in Materials and methods. Using this technique, we
were able to confirm the existence of those P2Y receptors
previously shown in the immunohistochemical studies. It is
important to point out that we had some problems in the
retinal preparations to get a positive band against the P2Y6
receptor. We still do not know the reason why it is not
possible to obtain a positive Western blot for this receptor.
In contrast, it was possible to see the mentioned band in the
corneal extracts (Figure 7). P2Y1,P 2 Y 2, P2Y4 and P2Y6
receptors presented molecular weights of 42, 50, 92 and 97
kDa, respectively. The other antibodies, like the one for the
P2Y11, did not reveal any positive band.
Discussion
P2Y receptors in the cornea and sclera
Metabotropic receptors for nucleotides in the cornea have
been identified by means of in situ hybridisation techniques.
P2Y2 receptors are predominantly expressed in the cornea,
sclera, goblet cells and meibomian glands of monkeys and
rabbits [12]. In our experiments, we describe P2Y2
receptors and the presence of P2Y1, P2Y4 and P2Y6. The
differences between our results and those described in the












P2Y1 ++ + + ++ ++ +
P2Y2 +++ + ++ ++ ++ +
P2Y4 ++ + + ++ j ++
P2Y6 ++ + jj j j
P2Y11 jj j + jj
j, No labelling, +, low labeling, ++, moderate labelling, +++, strong labelling.
Table 2. Distribution of P2Y receptors in the retina.
Receptor Reinal pigmented epithelium Photoreceptors Inner plexiform layer Outer plexiform layer Ganglion cell layer
P2Y1 jj j j j
P2Y2 +++ + jjj
P2Y4 + +++ j ++ ++
P2Y6 j +++ + ++ ++
P2Y11 jj j j j
j, No labelling, +, low labeling, ++, moderate labelling, +++, strong labelling.
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corneal epithelium the possible existence of P2Y4 and P2Y6
receptors cannot be discarded. Experiments studying the
effect of nucleotides on corneal wound healing demonstrate
that, apart from the involvement of a P2Y2 receptor in the
re-epithelialisation process, the participation of P2Y4/P2Y6
receptors needs to be taken into consideration [13].
In the endothelium, the existence of receptors for ATP
has been demonstrated. These receptors are of the P2Y
subtype, although there are not a detailed description of the
particular subtype [14]. We may suggest, according to our
results, that P2Y2 and P2Y4 are good candidates to fulfill
the results described by Srinivas, who clearly identified
different responses, therefore suggesting the presence of
more than one P2Y receptor subtype.
P2Y4 receptors have been also identified by in situ
hybridisation techniques in the conjunctiva, and a role on
the CI
j movement on conjunctival epithelial cells has been
suggested. Hosoya et al. [15] indicate that P2Y2 and P2Y4
receptors control the ion flux across the conjunctiva. This
ion flux can be measured by activating P2Y2 receptors with
UTP. This receptor stimulation produces a clear movement
of CI
j ions and the concomitant fluid transport [16].
Conjunctival goblet cells can modulate the release of
mucins by means of P2Y2 receptors, as suggested by Dartt
[17] and Murakami and co-workers [l8].
P2Y receptors in the iris ciliary body
There is not much information about the presence of P2
receptors in the iris. We have observed the presence of
P2Y1, P2Y2 and mainly P2Y4. Previous functional studies
demonstrated the presence of P2Y receptors, although
nothing indicated the receptor subtype. In these studies,
Fuder and co-workers [19] demonstrated the effect of ATP
on the iris, and how this effect is mediated by a P2Y-like
receptor [20]. P2Y receptors present in the iris may
regulate the pupil size by either controlling the muscle
contraction/relaxation or by modulating the sympathetic
nervous system which controls the iris physiology [20].
Concerning the ciliary body, the presence of P2Y
receptors has been demonstrated in pigmented and non-
pigmented epithelial cells by measuring IP3 generation and
cytosolic Ca
2+ levels [21]. Other experiments performed by
Shaindullah and Wilson [22] also demonstrate that the
effects of UTP and ATP are equipotent and that the
receptors they activate may belong to the P2Y2 purinocep-
tor subtype. In our case, we have been able to identify
different P2Y receptors; nevertheless, we were able to see a
differential distribution of the receptors in the ciliary
processes. P2Y1, P2Y2 and P2Y4 showed immunoreactivity
in the ciliary non-pigmented and pigmented epithelium.
The existence of P2Y2 receptors in non-pigmented and
pigmented epithelial cells has been described by in situ
hybridisation techniques [12]. This P2Y2 receptors and also
P2Y1 have been described in the rabbit ciliary body
epithelium by means of functional studies that reveal the
metabotropic nature of these receptors [7]. These receptors,
when activated, can increase cytosolic Ca
2+ levels plus
PGE2 and cAMP. This combination produces the activa-
tion of chloride channels which reduce the aqueous
humour formation and a reduction in IOP [23]. The
P2Y6 receptor appears only in the stroma of the ciliary
processes. This fact could be due to the existence of a
fenestrated blood vessel network in this area. Since P2Y6
receptors have been described in the endothelium of blood
vessels [24], it could be the case that our results are
showing positive immunoreactivity to the P2Y6 receptor
present in the vessels that can modify the blood flow in this
area.
Concerning the trabecular meshwork, our results, indi-
cating the presence of P2Y1 P2Y2 and P2Y4 in the rat
slices, cope quite well with the results described recently
by Crosson and co-workers [6]. They also described the
presence of P2Y11 in a human trabecular meshwork cells
line [6]. We were not able to see a positive immunoreac-
tivity against this receptor in the rat eye slices.
P2Y receptors in the retina
The distribution in the retina concerning the P2Y receptor
is complicated, mainly due to the great cellular heteroge-
neity. The presence of P2Y2 receptors has been demon-
strated in the retinal pigmented epithelium (RPE) in situ
hybridisation [12], and functional studies [11]. These
studies fit well with our results, which indicate strong
immunoreactivity to the P2Y2 receptor. The role of this
P2Y2 receptor seems to be very interesting from the
therapeutic point of view The presence of this receptors
on the apical membrane of RPE cells is very important for
the re-absorption of fluids present in the inter-retinal space
[25]. This fact has invited us to think about the possibility
of using selective P2Y2 agonists for the treatment of
pathologies such as the retinal detachment.
In the neural retina, and comparing our P2Y2 results
with others previously published, we were unable to see
labelling in other retinal areas apart from the photo-
receptors. This is in clear contrast with the results of
Cowlen et al. [11], who described the presence of P2Y2
mRNA in the inner nuclear layer and ganglion cell layer.
The other P2Y receptor which showed imunoreactivity
in the neural retina was the P2Y6 receptor, which was
present at the synaptic location (the plexiform layers) as
indicated by the co-localisation with synaptophysin.
Only P2X1 receptors have been described as associated
to the plexiforms layers in the retina; these include P2X1
[26–29].
Vinmentin antibody is a useful tool to identify Mu ¨ller
cells in the retina [30]. In this sense, we have been able to
identify P2Y4 and P2Y6 co-localisation with vimentin in
retinal slices, indicating the presence of these two
purinoceptors subtypes in Mu ¨ller cells. Reports about the
presence of P2Y receptors in glial cells have been done
[31, 32]. The existence of a P2Y receptors in Mu ¨ller cells
produces the typical increase in the cytosolic Ca
2+ levels
[33]. Recently, Bringmann and co-workers [34] have
demonstrated how P2Y receptors can modify physiological
P2Y receptors in the eye 87Figure 4. Presence of P2Y2 and P2Y11 in the RPE. Labelling to the
P2Y2 receptor was obtained in the retinal pigmented epithelium (upper
pictures). Combination with synaptophysin labelling permits a better
identification of the retinal areas. P2Y11 receptors were also present in the
RPE as observed in the three lower pictures. Scale bar, 10 mm.
Figure 5. Distribution of P2Y4 receptors in the retina. (A) Schematic
diagram showing the main cells in the retina, the synapses, and how they
are related. (B) The presence of P2Y4 receptors in the retina. Upper panel,
labelling with the P2Y4 receptor antibody presenting positive staining in
the external segments of photoreceptors (OS), outer plexiform layer (OPL)
and ganglion cell layer (GCL). Mid panel, synaptophysin staining
labelling the synaptic layer outer plexifom layer (OPL) and inner
plexiform layer (IPL). Lower panel, combination of the upper and mid
panels.
Figure 7. Western blot for the P2Y receptors in corneal extracts.
Analysis of the P2Y receptors present in the cornea by Western blot
analysis following the protocol described in Materials and methods. The
molecular weights of the identified bands fit quite well with those
described in the literature.
Figure 6. Study on the co-localisation of P2Y4 and P2Y6 receptors with
vimentin (Mu ¨ller cells). Upper pictures represent the labelling with the
P2Y4 receptor antibody (upper), with the vimentin (mid) antibody and a
combination of both (lower). Lower pictures represent the labelling of
P2Y6 receptors (upper), vimentin (mid) and a combination of both (lower).
Scale bar, 10 mm.
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+ turnover in Mu ¨ller cells, which is a
crucial aspect in the neurophysiology of the retina.
Very recently, Fries and co-workers [35] described the
expression of P2Y receptors in the rat retina. The use of in
situ hybridization techniques demonstrated the presence of
P2Y1, 4 and 6 in the inner layers of the retina. We have
similar results with the P2Y4 and P2Y6 receptor antibodies;
nevertheless, we do not get labelling with the P2Y2. Also,
and in clear contrast with the results presented by these
authors, we do not observe labelling with the P2Y1 and
P2Y2 in the ganglion cell layer but we do find the P2Y4
receptor. This group also describes immunoreactivity to the
P2Y1 and P2Y4 in the inner plexiform layer. In our case,
the only receptor located in this retinal area is the P2Y6.
The differences among our results and the ones described
by Fries et al., can be, in part, due to the strain and age of
the animals (they used Brown Norway, we used Wistar;
they used adults, we used young animals). Changes in the
results can also be due to the methodologies used by both
groups, which differ slightly.
In summary, P2Y receptors are widely distributed in the
eye. Some of the receptors were identified as P2Y although
they have not been fully characterised to know which of
the P2Y subtype is present in each area. We hope that this
work will help researchers to apply better pharmacological
tools when investigating these receptors in the different
ocular structures.
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